Cross Atlantic Commodities and Mercatis Media sign Online Advertising Agreement

NewsGuard 100/100 Score

Cross Atlantic Commodities, Inc. (Pink Sheets:CXAC), a successful manufacturer of specialty health and beauty products, announced signing an Online Advertising Agreement with Mercatis Media, LLC, Los Angles California.

“Signing this Agreement is significant for CXAC. Mercatis Media, is a full service Media Company. Our contract calls for them to take our existing creative, (banners and email campaigns), review them with their team of marketing experts, optimize them to get better conversion rates…The bottom line is all about increasing sales,” said Jorge Bravo, CEO.

The Company’s creative team will work with Mercatis, utilizing existing work and adding their own expertise. Mercatis will also purchase online media; which includes email advertising, revenue share arrangements, SEM, online catalogs and other sites that stream online content.

CXAC will run a series of four tests lasting 4 weeks. These tests are for obtaining data for our media funding partner; who will begin funding the company after their review of collected data. This, with our TV Launch, is by far the most aggressive marketing campaign that CXAC has done.

Management continues its efforts to create sales and in doing so, increasing Shareholder value.  

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.